The proto CpG island methylator phenotype of sessile serrated adenomas/polyps

Epigenetics

Volumn 13, Issue 10-11, 2018, Pages 1088-1105

  Parker, Hannah R ^a   Orjuela, Stephany ^a   Martinho Oliveira, Andreia ^a   Cereatti, Fabrizio ^b   Sauter, Matthias ^c   Heinrich, Henriette ^c   Tanzi, Giulia ^b   Weber, Achim ^a   Komminoth, Paul ^c   Vavricka, Stephan ^c   Albanese, Luca ^a   Buffoli, Federico ^b   Robinson, Mark D ^a   Marra, Giancarlo ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b CREMONA HOSPITAL   (Italy)

^c TRIEMLI HOSPITAL   (Switzerland)

Author keywords

adenomatous polyp; colon cancer; DNA methylation; Sessile serrated adenoma polyp

Indexed keywords

CYTOSINE; TRANSCRIPTOME;

ADENOMATOUS POLYP; ARTICLE; BRAF GENE; COLON INJURY; COLONOSCOPY; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE; GENE EXPRESSION; GENE MUTATION; GENE REGULATORY NETWORK; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KRAS GENE; MICROARRAY ANALYSIS; NEXT GENERATION SEQUENCING; PHENOTYPE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PYROSEQUENCING; QUALITY CONTROL; RECTUM ADENOMA; SANGER SEQUENCING; UPREGULATION; ADENOMA; AGED; COLON POLYP; COLON TUMOR; FEMALE; GENETICS; MALE; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

ADENOMA; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; COLONIC POLYPS; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE;

EID: 85057294888     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.1080/15592294.2018.1543504     Document Type: Article

References (85)

1. Jass JR, Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol. 2005 Aug;2(8):398–405. PubMed PMID: 16130936
2. Phipps AI, Limburg PJ, Baron JA, et al. Association between molecular subtypes of colorectal cancer and patient survival. Gastroenterology. 2015 Jan;148(1):77–87 e2. PubMed PMID: 25280443; PubMed Central PMCID: PMCPMC4274235
3. Hinoue T, Weisenberger DJ, Lange CP, et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res. 2012 Feb;22(2):271–282. PubMed PMID: 21659424; PubMed Central PMCID: PMCPMC3266034
4. Okugawa Y, Grady WM, Goel A, Epigenetic alterations in colorectal cancer: emerging biomarkers. Gastroenterology. 2015 Oct;149(5):1204–1225 e12. PubMed PMID: 26216839; PubMed Central PMCID: PMCPMC4589488
5. Ijspeert JEG, Vermeulen L, Meijer GA, et al. Serrated neoplasia-role in colorectal carcinogenesis and clinical implications. Nat Rev Gastroenterol Hepatol. 2015 Jul;12(7):401–409. PubMed PMID: 25963511
6. Bettington M, Walker N, Clouston A, et al. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology. 2013 Feb;62(3):367–386. PubMed PMID: 23339363
7. Toyota M, Ahuja N, Ohe-Toyota M, et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8681–8686. PubMed PMID: 10411935; eng
8. Deaton AM, Bird A, CpG islands and the regulation of transcription. Genes Dev. 2011 May 15;25(10):1010–1022. PubMed PMID: 21576262; PubMed Central PMCID: PMCPMC3093116
9. Feinberg AP, Ohlsson R, Henikoff S, The epigenetic progenitor origin of human cancer. Nat Rev Genet. 2006 Jan;7(1):21–33. PubMed PMID: 16369569
10. Jones PA, Baylin SB, The epigenomics of cancer. Cell. 2007 Feb 23;128(4):683–692. PubMed PMID: 17320506; PubMed Central PMCID: PMCPMC3894624
11. Issa JP, Aging and epigenetic drift: a vicious cycle. J Clin Invest. 2014 Jan;124(1):24–29. PubMed PMID: 24382386; PubMed Central PMCID: PMCPMC3871228
12. Rodriguez-Paredes M, Esteller M., Cancer epigenetics reaches mainstream oncology. Nat Med. 2011 Mar;17(3):330–339. PubMed PMID: 21386836
13. Boland CR, Goel A, Microsatellite instability in colorectal cancer. Gastroenterology. 2010 Jun;138(6):2073–2087 e3. PubMed PMID: 20420947; PubMed Central PMCID: PMCPMC3037515
14. O’Brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol. 2006 Dec;30(12):1491–1501. PubMed PMID: 17122504
15. Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet. 2006 Jul;38(7):787–793. PubMed PMID: 16804544; eng
16. Bettington M, Walker N, Rosty C, et al. Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma. Gut. 2017 Jan;66(1):97–106. PubMed PMID: 26475632
17. Carethers JM, Smith EJ, Behling CA, et al. Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology. 2004 Feb;126(2):394–401. PubMed PMID: 14762775
18. Le DT, Uram JN, Wang H, et al. PD-1 blockade in tumors with mismatch-repair deficiency. New Engl J Med. 2015 Jun 25;372(26):2509–2520. PubMed PMID: WOS:000356788200007; English
19. Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumors of the digestive system. Lyon: International Agency for Research on Cancer Publisher; 2010
20. Kambara T, Simms LA, Whitehall VL, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut. 2004 Aug;53(8):1137–1144. PubMed PMID: 15247181
21. Rex DK, Ahnen DJ, Baron JA, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012 Sep;107(9):1315–29; quiz 1314, 1330. PubMed PMID: 22710576; PubMed Central PMCID: PMCPMC3629844
22. Fang M, Ou J, Hutchinson L, et al. The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island methylator phenotype. Mol Cell. 2014 Sep 18;55(6):904–915. PubMed PMID: 25219500; PubMed Central PMCID: PMCPMC4170521
23. Carragher LA, Snell KR, Giblett SM, et al. V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Mol Med. 2010 Nov;2(11):458–471. PubMed PMID: 20941790; PubMed Central PMCID: PMCPMC3394506
24. Rad R, Cadinanos J, Rad L, et al. A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic intervention. Cancer Cell. 2013 Jul 8;24(1):15–29. PubMed PMID: 23845441; PubMed Central PMCID: PMCPMC3706745
25. Sakamoto N, Feng Y, Stolfi C, et al. BRAF(V600E) cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis. Elife. 2017 Jan 10;6. doi: 10.7554/eLife.20331. PubMed PMID: 28072391; PubMed Central PMCID: PMCPMC5268782
26. Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US multi-society task force on colorectal cancer. Gastroenterology. 2012 Sep;143(3):844–857. PubMed PMID: 22763141
27. Singh H, Nugent Z, Demers AA, et al. The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology. 2010 Oct;139(4):1128–1137. PubMed PMID: 20600026
28. East JE, Vieth M, Rex DK, Serrated lesions in colorectal cancer screening: detection, resection, pathology and surveillance. Gut. 2015 Jun;64(6):991–1000. PubMed PMID: 25748647
29. Gourevitch RA, Rose S, Crockett SD, et al. Variation in pathologist classification of colorectal adenomas and serrated polyps. Am J Gastroenterol. 2018 Jan 30. PubMed PMID: 29380819. 113 431–439
30. Pohl H, Srivastava A, Bensen SP, et al. Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology. 2013 Jan;144(1):74–80 e1. PubMed PMID: 23022496
31. Bettington M, Walker N, Rosty C, et al. Critical appraisal of the diagnosis of the sessile serrated adenoma. Am J Surg Pathol. 2014 Feb;38(2):158–166. PubMed PMID: 24418851
32. Sawhney MS, Farrar WD, Gudiseva S, et al. Microsatellite instability in interval colon cancers. Gastroenterology. 2006 Dec;131(6):1700–1705. PubMed PMID: 17087932
33. Bird AP, Use of restriction enzymes to study eukaryotic dna methylation.2. Symmetry of methylated sites supports semi-conservative copying of methylation pattern. J Mol Biol. 1978;118(1):49–60. PubMed PMID: WOS:A1978EM86300003; English
34. Wu H, Zhang Y, Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell. 2014 Jan 16; 156 (1–2): 45–68. PubMed PMID: 24439369; PubMed Central PMCID: PMCPMC3938284
35. Menigatti M, Cattaneo E, Sabates-Bellver J, et al. The protein tyrosine phosphatase receptor type R gene is an early and frequent target of silencing in human colorectal tumorigenesis. Mol Cancer. 2009;8:124. doi: 1476-4598-8-124 [pii]
36. Menigatti M, Truninger K, Gebbers JO, et al. Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters. Oncogene. 2009 Feb 12;28(6):899–909. PubMed PMID: 19060925; eng
37. Menigatti M, Staiano T, Manser CN, et al. Epigenetic silencing of monoallelically methylated miRNA loci in precancerous colorectal lesions. Oncogenesis. 2013 Jul 15;2:e56. PubMed PMID: 23857251; PubMed Central PMCID: PMCPMC3740287
38. Suzuki H, Watkins DN, Jair KW, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet. 2004 Apr;36(4):417–422. PubMed PMID: 15034581
39. Nikolaev SI, Sotiriou SK, Pateras IS, et al. A single-nucleotide substitution mutator phenotype revealed by exome sequencing of human colon adenomas. Cancer Res. 2012 Dec 1;72(23):6279–6289. PubMed PMID: 23204322
40. Lin SH, Raju GS, Huff C, et al. The somatic mutation landscape of premalignant colorectal adenoma. Gut. 2017 Jun 12. doi: 10.1136/gutjnl-2016-313573. PubMed PMID: 28607096
41. Dehghanizadeh S, Khoddami V, Mosbruger TL, et al. Active BRAF-V600E is the key player in generation of a sessile serrated polyp-specific DNA methylation profile. PLoS One. 2018;13(3):e0192499. PubMed PMID: 29590112; PubMed Central PMCID: PMCPMC5873940
42. Di Pietro M, Bellver JS, Menigatti M, et al. Defective DNA mismatch repair determines a characteristic transcriptional profile in proximal colon cancers. Gastroenterology. 2005 Sep;129(3):1047–1059. PubMed PMID: 16143142
43. Lin JC, Jeong S, Liang G, et al. Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island. Cancer Cell. 2007 Nov;12(5):432–444. PubMed PMID: 17996647; PubMed Central PMCID: PMCPMC4657456
44. Jones PA, Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012 May 29;13(7):484–492. PubMed PMID: 22641018
45. Kim YH, Kakar S, Cun L, et al. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps. Int J Cancer. 2008 Dec 01;123(11):2587–2593. PubMed PMID: 18798261
46. Vaughn CP, Wilson AR, Samowitz WS, Quantitative evaluation of CpG island methylation in hyperplastic polyps. Mod Pathol. 2010 Jan;23(1):151–156. PubMed PMID: 19855373
47. Maeda T, Suzuki K, Togashi K, et al. Sessile serrated adenoma shares similar genetic and epigenetic features with microsatellite unstable colon cancer in a location-dependent manner. Exp Ther Med. 2011 Jul;2(4):695–700. PubMed PMID: 22977561; PubMed Central PMCID: PMCPMC3440750
48. Dhir M, Yachida S, Van Neste L, et al. Sessile serrated adenomas and classical adenomas: an epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract. Int J Cancer. 2011 Oct 15;129(8):1889–1898. PubMed PMID: 21154739; PubMed Central PMCID: PMCPMC3206997
49. Burnett-Hartman AN, Newcomb PA, Potter JD, et al. Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. Cancer Res. 2013 May 1;73(9):2863–2872. PubMed PMID: 23539450; PubMed Central PMCID: PMCPMC3815695
50. Fernando WC, Miranda MS, Worthley DL, et al. The CIMP phenotype in BRAF mutant serrated polyps from a prospective colonoscopy patient cohort. Gastroenterol Res Pract. 2014;2014:1–10. PubMed PMID: 24812557; PubMed Central PMCID: PMCPMC4000649
51. Yamamoto E, Suzuki H, Yamano HO, et al. Molecular dissection of premalignant colorectal lesions reveals early onset of the CpG island methylator phenotype. Am J Pathol. 2012 Nov;181(5):1847–1861. PubMed PMID: 22995252
52. Worthley DL, Whitehall VL, Buttenshaw RL, et al. DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. Oncogene. 2010 Mar 18;29(11):1653–1662. PubMed PMID: 19966864
53. Park SJ, Rashid A, Lee JH, et al. Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol. 2003 Mar;162(3):815–822. PubMed PMID: 12598316
54. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014 Apr 03;370(14):1287–1297. PubMed PMID: 24645800
55. Herman JG, Umar A, Polyak K, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6870–6875. PubMed PMID: 9618505
56. Truninger K, Menigatti M, Luz J, et al. Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. Gastroenterology. 2005 May;128(5):1160–1171. PubMed PMID: 15887099
57. Reed KR, Korobko IV, Ninkina N, et al. Hunk/Mak-v is a negative regulator of intestinal cell proliferation. BMC Cancer. 2015 Mar 8;15:110. doi: 10.1186/s12885-015-1087-2. PubMed PMID: 25881306; PubMed Central PMCID: PMCPMC4367870
58. Yeh ES, Belka GK, Vernon AE, et al. Hunk negatively regulates c-myc to promote Akt-mediated cell survival and mammary tumorigenesis induced by loss of pten. Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6103–6108. PubMed PMID: 23520049; PubMed Central PMCID: PMCPMC3625285
59. Bergman Y, Cedar H, DNA methylation dynamics in health and disease. Nat Struct Mol Biol. 2013 Mar;20(3):274–281. PubMed PMID: 23463312
60. Schlesinger Y, Straussman R, Keshet I, et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet. 2007 Feb;39(2):232–236. PubMed PMID: 17200670
61. Widschwendter M, Fiegl H, Egle D, et al. Epigenetic stem cell signature in cancer. Nat Genet. 2007 Feb;39(2):157–158. PubMed PMID: 17200673
62. Mohn F, Weber M, Rebhan M, et al. Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol Cell. 2008 Jun 20;30(6):755–766. PubMed PMID: 18514006
63. Reddington JP, Pennings S, Meehan RR, Non-canonical functions of the DNA methylome in gene regulation. Biochem J. 2013 Apr 1;451(1):13–23. PubMed PMID: 23489368
64. Manzo M, Wirz J, Ambrosi C, et al. Isoform-specific localization of DNMT3A regulates DNA methylation fidelity at bivalent CpG islands. Embo J. 2017 Dec 1;36(23):3421–3434. PubMed PMID: 29074627; PubMed Central PMCID: PMCPMC5709737
65. Easwaran H, Johnstone SE, Van Neste L, et al. A DNA hypermethylation module for the stem/progenitor cell signature of cancer. Genome Res. 2012 May;22(5):837–849. PubMed PMID: 22391556; PubMed Central PMCID: PMCPMC3337430
66. Ong CT, Corces VG, CTCF: an architectural protein bridging genome topology and function. Nat Rev Genet. 2014 Apr;15(4):234–246. PubMed PMID: 24614316; PubMed Central PMCID: PMCPMC4610363
67. Yin Y, Morgunova E, Jolma A, et al. Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science. 2017 May 05;356(6337). doi: 10.1126/science.aaj2239. PubMed PMID: 28473536
68. Flavahan WA, Drier Y, Liau BB, et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature. 2016 Jan 07;529(7584):110–114. PubMed PMID: 26700815; PubMed Central PMCID: PMCPMC4831574
69. Wang H, Maurano MT, Qu H, et al. Widespread plasticity in CTCF occupancy linked to DNA methylation. Genome Res. 2012 Sep;22(9):1680–1688. PubMed PMID: 22955980; PubMed Central PMCID: PMCPMC3431485
70. Yan H, Tang G, Wang H, et al. DNA methylation reactivates GAD1 expression in cancer by preventing CTCF-mediated polycomb repressive complex 2 recruitment. Oncogene. 2016 Jul 28;35(30):3995–4008. PubMed PMID: 26549033
71. Neri F, Rapelli S, Krepelova A, et al. Intragenic DNA methylation prevents spurious transcription initiation. Nature. 2017 Mar 2;543(7643):72–77. PubMed PMID: 28225755
72. Maunakea AK, Nagarajan RP, Bilenky M, et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature. 2010 Jul 8;466(7303):253–257. PubMed PMID: 20613842; PubMed Central PMCID: PMCPMC3998662
73. Kim JH, Kim KJ, Rhee YY, et al. Gastric-type expression signature in serrated pathway-associated colorectal tumors. Hum Pathol. 2015 May;46(5):643–656. PubMed PMID: 25704805
74. Delker DA, McGettigan BM, Kanth P, et al. RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers. PLoS One. 2014;9(2):e88367. PubMed PMID: 24533081; PubMed Central PMCID: PMCPMC3922809
75. Sajanti SA, Vayrynen JP, Sirnio P, et al. Annexin A10 is a marker for the serrated pathway of colorectal carcinoma. Virchows Arch. 2015 Jan;466(1):5–12. PubMed PMID: 25395067
76. Caruso M, Moore J, Goodall GJ, et al. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Virchows Arch. 2009 Mar;454(3):291–302. PubMed PMID: 19172291
77. Gonzalo DH, Lai KK, Shadrach B, et al. Gene expression profiling of serrated polyps identifies annexin A10 as a marker of a sessile serrated adenoma/polyp. J Pathol. 2013 Aug;230(4):420–429. PubMed PMID: 23595865
78. De Sousa E Melo F, Wang X, Jansen M, et al. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nat Med. 2013 May;19(5):614–618. PubMed PMID: 23584090
79. Kanth P, Bronner MP, Boucher KM, et al. Gene signature in sessile serrated polyps identifies colon cancer subtype. Cancer Prev Res (Phila). 2016 Jun;9(6):456–465. doi: 10.1158/1940-6207.CAPR-15-0363. PubMed PMID: 27026680; PubMed Central PMCID: PMCPMC4941619
80. Rahmatallah Y, Khaidakov M, Lai KK, et al. Platform-independent gene expression signature differentiates sessile serrated adenomas/polyps and hyperplastic polyps of the colon. BMC Med Genomics. 2017 Dec 28;10(1):81. doi: 10.1186/s12920-017-0317-7. PubMed PMID: 29284484; PubMed Central PMCID: PMCPMC5745747
81. Endoscopic Classification Review Group. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy. 2005 Jun;37(6):570–578. PubMed PMID: 15933932
82. Krueger F, Andrews SR, Bismark: a flexible aligner and methylation caller for bisulfite-seq applications. Bioinformatics. 2011 Jun 1;27(11):1571–1572. PubMed PMID: 21493656; PubMed Central PMCID: PMCPMC3102221
83. Patro R, Duggal G, Love MI, et al. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017 Apr;14(4):417–419. PubMed PMID: 28263959; PubMed Central PMCID: PMCPMC5600148
84. Hebestreit K, Dugas M, Klein HU. Detection of significantly differentially methylated regions in targeted bisulfite sequencing data. Bioinformatics. 2013 Jul 1;29(13):1647–1653. PubMed PMID: 23658421
85. Robinson MD, McCarthy DJ, Smyth GK, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010 Jan 1;26(1):139–140. PubMed PMID: 19910308; PubMed Central PMCID: PMCPMC2796818